Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Prepaid Assets (2016 - 2025)

ProQR Therapeutics' Prepaid Assets history spans 6 years, with the latest figure at $3.1 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 18.74% to $3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.1 million, a 18.74% increase, with the full-year FY2025 number at $3.1 million, up 18.74% from a year prior.
  • Prepaid Assets hit $3.1 million in Q4 2025 for ProQR Therapeutics, up from $2.6 million in the prior quarter.
  • Over the last five years, Prepaid Assets for PRQR hit a ceiling of $60.3 million in Q4 2022 and a floor of $5469.1 in Q1 2021.
  • Historically, Prepaid Assets has averaged $9.2 million across 5 years, with a median of $3.9 million in 2021.
  • The widest YoY moves for Prepaid Assets: up 82950.63% in 2022, down 87.0% in 2022.
  • Tracing PRQR's Prepaid Assets over 5 years: stood at $3.9 million in 2021, then soared by 1447.84% to $60.3 million in 2022, then tumbled by 93.49% to $3.9 million in 2023, then plummeted by 34.38% to $2.6 million in 2024, then rose by 18.74% to $3.1 million in 2025.
  • Business Quant data shows Prepaid Assets for PRQR at $3.1 million in Q4 2025, $2.6 million in Q4 2024, and $3.9 million in Q3 2023.